Abu Dhabi Securities Exchange logo

Abu Dhabi Securities Exchange

United Arab Emirates · Middle East · XADS

Post

Abu Dhabi Securities Exchange is a stock exchange based in United Arab Emirates (Middle East), identified by the ISO 10383 market code XADS. On Traderforum, traders discuss listings, market sentiment and trade ideas connected to United Arab Emirates's markets. Follow the conversation, share analysis, and track bull/bear sentiment across the instruments that matter to Abu Dhabi Securities Exchange participants.

Discussion connected to United Arab Emirates markets

10

Thoughts on $VNM and the EM rebound post-CPI

Watching $VNM today, that +4.20% move to 17.87 off the back of a fairly flat $CPI print is interesting. We've seen a lot of folks worried about inflation pressure stalling EM growth, but this $CPI at 25.6047 feels like it's giving some room to breathe. My gut tells me we're looking at a decent chance for $VNM to test 18.50 by month-end, maybe 60% probability. The reasoning is that with the inflation scare potentially fading a bit, and a decent floor established around 17.68, there's likely some sidelined capital looking to redeploy into EM. Of course, any major shift in the macro narrative globally, or unexpected hawkishness from central banks, could derail that pretty quick. But for now, the path of least resistance feels like a grind higher.

17

EM FX: Don't chase the rally, especially when you're late

Biggest mistake I made last year was chasing the $MXN rally after it broke 18.00. Had been watching it for weeks, knew the carry was attractive, but hesitated on entry. Once it really started moving, I felt that FOMO kick in and piled in, thinking I was still early enough for a quick swing. Of course, it wicked right up to 17.50, I got in near the top, and then it bounced off that level and spent the next few weeks consolidating, taking out my stop.

Lesson learned: If you missed the initial move, resist the urge to jump into an extended rally. There's always another trade. Chasing momentum when you're already behind the curve just increases your risk and puts you in a psychologically weak position. Better to wait for a pullback or move on to the next setup.

2

บทเรียนจากความใจร้อนในตลาด EM

ผมเคยพลาดกับการเทรดในตลาดเกิดใหม่ช่วงที่มันผันผวนหนักๆ แทนที่จะรอจังหวะเข้าตามแผน ดันไป FOMO ซื้อตามเพราะกลัวตกรถ สุดท้ายก็โดนลากกลับมาเข้าเนื้อพอสมควร มันย้ำเตือนว่าการรีบเทรดโดยไม่มีวินัยนี่แหละคือบ่อเกิดของความเสียหายที่แท้จริง.

4

Watching $Y on the daily

Been looking at the YPF ($Y) daily chart. We're right at that 847.60-847.80 resistance zone. It's been pretty sticky there for a while now. If we can punch through and hold above 848, I think we could see some real momentum pick up. My concern is a retrace if it fails to break here, especially if we get a quick rejection off this level. Below 840 and this whole idea is probably toast for now.

15
PLr/stocks·by u/plimpongsa·1moDiscussion

เรื่องของอินดิเคเตอร์กับ Price Action ในตลาดหุ้น

ผมเห็นบางคนยังยึดติดกับอินดิเคเตอร์อย่าง MACD หรือ RSI มากๆ ในการเทรด $FFR ซึ่งวันนี้ก็วิ่งดี +1.28% ที่ 36.8818 แต่ส่วนตัวผมยังรู้สึกว่า Price Action มันมีพลังมากกว่า อินดิเคเตอร์มันก็แค่ค่าที่ได้มาจากราคาในอดีตเท่านั้นเอง มันไม่ได้บอกอนาคต และหลายครั้งที่กว่าอินดิเคเตอร์จะคอนเฟิร์ม ราคาก็ไปไกลแล้ว เสี่ยงที่จะโดน False Signal ได้ง่ายๆ ไม่ว่าจะในหุ้น หรือแม้แต่ในตลาดคู่เงินอย่าง $EURCAD ที่ตอนนี้ก็ย่อมานิดหน่อย -0.17% ที่ 1.607 บางทีการเฝ้าดูแท่งเทียน การดูรูปแบบราคา การหาแนวรับแนวต้านที่ชัดเจน มันให้ข้อมูลที่เรียลไทม์กว่า และทำให้เราตัดสินใจได้คมกว่ารึเปล่า? มีใครเห็นต่างไหมครับ อยากฟังมุมมองอื่น

5
ZAr/stocks·by u/zeynep.arslan·1moDiscussion

My first big mistake: thinking a 'sure thing' was actually sure

Been trading stocks for about a year now, mostly small caps and some blue chips. My biggest lesson so far was early on, thinking I'd found a 'sure thing' in a biotech firm ($BTEC) with a drug in phase 3 trials. The chatter was immense, analysts were bullish, and I just jumped in without really doing my own deep dive into their financials beyond the headline news.

I sized way too large for my account, confident it would double on the announcement. When the trial results came back with mixed efficacy, the stock plummeted. I held on for dear life, averaging down a bit, thinking it had to recover. It didn't. Ended up taking a painful loss that wiped out several months of small wins. Taught me a hard lesson about due diligence, position sizing, and not letting market sentiment completely override your own research. Still stings a bit thinking about it.

5
TUr/stocks·by u/tuanrahman·1moAnalysis

BDL testing highs, watching 48.48 for conviction

Interesting to see BDL today pushing up to 48.12, really knocking on the door of that 48.48 level it hit earlier. It looks like there's some decent buying pressure trying to clear that previous intraday high. If it can get a solid close above that 48.48 on decent volume, I'd consider that a pretty good sign of follow-through.

On the flip side, if it peters out here and rolls over, especially if it breaks back below 46.795, that would invalidate the current upward momentum for me. Just my two cents, always room to be wrong.

43
PRr/stocks·by u/priya28·1moDiscussion

Ignoring macro indicators when scaling into positions

One recurring error for me has been getting too caught up in the micro-structure of a stock and ignoring broader macro signals when scaling into a long-term position. Specifically, averaging down into $TSLA during early 2022 without properly weighing the rising interest rate environment and general market tightening was a hard lesson in humility; the technicals looked appealing, but the macro headwinds were too strong to ignore, and I ended up significantly overpaying for the initial entries.